Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …

Prostate cancer is the second most common cause of malignancy among men, with bone
metastasis being a significant source of morbidity and mortality in advanced cases …

Please see the Editorial Comment by Sungmin Woo discussing this article. BACKGROUND.
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …

Prostate-specific membrane antigen (PSMA) PET has a higher accuracy than CT and bone
scans to stage patients with prostate cancer. We do not understand how to apply clinical trial …

Simple Summary Accurate primary staging for determining the extent of prostate cancer is
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …

Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging... : Clinical Nuclear
Medicine Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal …

Objective: The aim of this study was to assess the diagnostic value of gallium-68-prostate
specific membra-8 ne antigen (6 Ga-PSMA) positron emission tomography/computed …

Purpose We aimed to investigate the diagnostic power of 68Ga-PSMA PET/CT in the
detection of metastatic spread of newly diagnosed PCa, and evaluate the relationship with …

Recent developments in hybrid SPECT/CT systems and the use of cadmium-zinc-telluride
(CZT) detectors have improved the diagnostic accuracy of bone scintigraphy. These …

While Tc-99m MDP bone scan (BS) remains the conventional standard for detection of bone
metastasis in prostate cancer, newly FDA-approved imaging with PSMA-based 18 F …